You’d think by now we’d know ALL the risks of statin drugs.
After all, they’ve been on the market for decades.
You might even believe the health authorities would WANT us to know what these drugs are doing to folks. And that the FDA would WARN us of potential problems and TAKE ACTION to limit the damage.
But here’s the truth.
That would require the folks at the top to care more about patients than drug industry profits. And that’s NOT the case.
Want proof? Look no further than the latest research, which exposes the ugly truth about a frightening new risk.
Since the feds won’t warn you about it, that means I have to.
Statins linked to staph infections
There’s no such thing as a “good” infection. But anyone who’s ever had staph can tell you staph infections are a special kind of horrible.
When you’re suffering from the painful, oozing blisters… burning fever… stomachaches and other problems… you might think you’re in the middle of some of the worst luck you’ve ever had.
But the new study shows how it might not be rotten luck at all. It may be a rotten MED instead.
Specifically, a statin drug. Which the new study finds can increase the risk of these infections by a staggering 40 percent. And that risk can turn up within just 90 days of starting to take the drug.
What makes this especially scary is that these infections aren’t just ugly and uncomfortable. They can also be deadly, killing as many as 30 percent of all patients.
In fact, one frightening study found that staph is deadlier than AIDS, tuberculosis, and viral hepatitis combined.
The cholesterol drug risk that’s a life sentence
But at least staph can go away… if you’re lucky.
The new study confirms yet another statin risk – one that won’t go away.
For millions of Americans, diabetes is a lifelong curse, they can never shake. It leads to meds and injections from the day they’re diagnosed to the day they die an early death due to the disease.
And that’s what these drugs can deliver, increasing your risk of diabetes by as much as 20 percent. And that’s actually a conservative estimate. Other studies have found the risk jumps by as much as 38 percent, especially if you already have some of the factors for diabetes.
And that’s not even the worst news of all. You face all that for a drug that attacks the WRONG target, to begin with. Because the problem was never LDL cholesterol alone.
In fact, by itself, the LDL number is almost meaningless.
What really matters is particle size and the damage of oxidative stress. That’s what causes the LDL to stick to arteries and clog them up even if you have perfectly “healthy” cholesterol levels.
Instead of cutting your LDL down to basement low levels with a drug, work on ensuring those particles continue to pass through harmlessly by switching to a healthy diet with no processed foods and plenty of natural antioxidants such as astaxanthin.